Tanja Rozman Peterka

Title: Tanja Rozman Peterka: Innovator in Pharmaceutical Formulations

Introduction

Tanja Rozman Peterka is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of quick-dissolving dosage forms. Her innovative work has the potential to enhance patient compliance and improve therapeutic outcomes.

Latest Patents

Tanja holds a patent for a stable quick-dissolving dosage form comprising amoxicillin and clavulanic acid. This quick-dissolving pharmaceutical formulation includes several key components: from about 35 to about 50 weight percent amoxicillin or a pharmaceutically acceptable salt thereof; from about 2.0 to about 12 weight percent clavulanic acid or a pharmaceutically acceptable salt thereof; from about 30 to about 40 weight percent mannitol; from about 2 to about 7 weight percent crospovidone; from about 0.5 to about 2.0 weight percent colloidal silicon dioxide; and from about 2.0 to about 5.0 weight percent sodium stearyl fumarate. Additionally, she has disclosed a method for making a quick-dissolving pharmaceutical tablet.

Career Highlights

Tanja is currently employed at Sandoz AG, a global leader in generic pharmaceuticals. Her work at Sandoz has allowed her to focus on innovative drug formulations that meet the needs of patients and healthcare providers alike.

Collaborations

Some of her notable coworkers include Rok Staric and Marko Oblak, who contribute to the collaborative environment at Sandoz AG.

Conclusion

Tanja Rozman Peterka's contributions to pharmaceutical innovations, particularly in quick-dissolving formulations, highlight her role as a key inventor in the industry. Her work not only advances pharmaceutical science but also aims to improve patient care through effective medication delivery systems.